Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.41 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 1/20 | 0.40 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.40 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30985279 | 1.00 | NOD1 (0.57) | NOD1KMT2ASOAT1MEN1FAAH | |
| SCHEMBL29245602 | 1.00 | NOD1 (0.57) | NOD1KMT2ASOAT1MEN1FAAH | |
| SCHEMBL27812063 | 1.00 | NOD1 (0.57) | NOD1KMT2ASOAT1MEN1FAAH | |
| SCHEMBL30255144 | 0.98 | NOD1 (0.56) | NOD1KMT2ASOAT1MEN1FAAH | |
| SCHEMBL28050915 | 0.94 | NOD1 (0.53) | NOD1KMT2ASOAT1MEN1FAAH | |
| SCHEMBL2120825 | 0.94 | NOD1 (0.53) | NOD1KMT2ASOAT1MEN1FAAH | |
| SCHEMBL21373143 | 0.94 | NOD1 (0.52) | NOD1KMT2ASOAT1MEN1FAAH | |
| SCHEMBL19873202 | 0.94 | NOD1 (0.52) | NOD1KMT2ASOAT1MEN1FAAH | |
| SCHEMBL29245559 | 0.92 | FAAH (0.58) | NOD1KMT2ASOAT1MEN1FAAH | |
| SCHEMBL10766310 | 0.90 | NOD1 (0.46) | NOD1KMT2ASOAT1MEN1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119604312-A | Lipid compositions for in vivo delivery | 生命技术公司 | 2025-03-11 | — | — | CN | disclosed |
| EP-0869937-A4 | NOVEL AMIDE-BASED CATIONIC LIPIDS | PROMEGA BIOSCIENCES INC (US) | 2004-07-21 | — | — | EP | disclosed |
| US-6638529-B2 | Lipid copound for use in the transfer macromolecules in cells | GENTA INCORPORATED | 2003-10-28 | — | — | US | disclosed |
| US-20020156237-A1 | Novel amide-based cationic lipids | PROMEGA BIOSCIENCES, INC. | 2002-10-24 | — | — | US | disclosed |
| US-6339173-B1 | FOR INTERFERING WITH PROTEIN EXPRESSION IN A CELL; USEFUL IN LIPID AGGREGATES FOR THE DELIVERY OF MACROMOLECULES INTO CELLS | PROMEGA BIOSCIENCES, INC. | 2002-01-15 | — | — | US | disclosed |
| US-6020526-A | Amide-based cationic lipids | GENTA, INCORPORATED (US) | 2000-02-01 | — | — | US | disclosed |
| EP-0869937-A1 | NOVEL AMIDE-BASED CATIONIC LIPIDS | GENTA INCORPORATED (US) | 1998-10-14 | — | — | EP | disclosed |
| WO-1997003939-A9 | NOVEL AMIDE-BASED CATIONIC LIPIDS | — | 1997-05-22 | — | — | WO | disclosed |
| WO-1997003939-A1 | NOVEL AMIDE-BASED CATIONIC LIPIDS | GENTA INCORPORATED (US) | 1997-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020156237-A1 | Novel amide-based cationic lipids | CETP, SGMS1, CERT1 | NOD1 1493/4885KMT2A 990/4885SOAT1 206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.